RH-35 Cells
US$ 395,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The H4-II-E (also referred to as RH-35) cell line is a derivative of the Reuber H-35 rat hepatoma. This cell line originated from a liver tumor induced in a male ACI rat by exposure to the chemical carcinogen N-2-fluorenyldiacetamide. When transplanted into ACI rats, H4-II-E cells form rapidly growing tumors with histological features characteristic of poorly differentiated hepatomas. They are particularly sensitive to the induction of aryl hydrocarbon hydroxylase (AHH) activity, making them a robust system for studying enzymatic responses to polycyclic aromatic hydrocarbons and dioxin-like compounds. H4-II-E cells also serve as a model for studying cellular responses to carcinogens and radiation, given their clonogenicity and the ability to assay long-term cell survival post-treatment. Their application extends to exploring the mechanisms of enzyme induction, xenobiotic metabolism, and liver-specific toxicology. These attributes make H4-II-E an invaluable tool in cancer research and toxicological screening. |
|---|---|
| Organismo | Rat |
| Tecido | Liver |
| Doença | Rat hepatocellular carcinoma |
| Sinônimos | H4II, H-35tc2, Reuber-H-35 hepatoma tissue culture 2, Reuber H-35 tc2, Reuber H35 tc2, H-35 Reuber tc2, H35 Reuber tc2, RH-35 tc2, RH35 tc2, H-35 tc2, H35 tc2 |
Características
| Raça/Subespécie | AxC |
|---|---|
| Gênero | Male |
| Morfologia | Epithelial |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | RH-35 (Cytion catalog number 305210) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 10116 |
| Número de acesso do Cellosaurus | CVCL_4623 |
Dados biomoleculares
Manuseio
| Meio de cultura | Ham's F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Renovação de fluidos | 2 to 3 times per week |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 305210-040823 | Certificado de Análise | 18. Aug. 2025 | 305210 |